Two glasses of cranberry juice a day may protect against the development of hardening of the arteries, according to a new study by scientists at the Mayo Clinic and College of Medicine.
The American Herbal Products Association (AHPA) has announced the winners of its seventh annual AHPA Awards with Mitchell Coven (Vitality Works), Roy Upton (American Herbal Pharmacopoeia) and Tom's of Maine honored.
The addition of pre and probiotics to infant formula could help to boost immune responses by colonising newborn babies’ guts with a stable population of beneficial bacteria, say researchers.
Utah-based direct selling supplements firm Nature's Sunshine Products (NSP) moved back into the black in the fourth quarter of 2011 posting a net profit on continuing operations of $7.6m vs a net loss of $0.4m a year ago.
The makers of the QuickTrim weight loss supplements endorsed by reality TV stars the Kardashians are making false, misleading and unsubstantiated claims about their efficacy, according to a class action lawsuit.
Three weeks of supplementation with a wheat bran extract may beneficially alter markers of gut health, say results of a placebo-controlled cross-over human intervention trial from Belgium.
Increased intakes of vitamin D may reduce the risk of stress fracture in adolescent girls, says a new study that adds to the potential health benefits of the sunshine vitamin.
A blend of policosanol, tomato extract, grape procyanidins and Oenothera biennis may reduce LDL and total cholesterol, according to a new study funded by Italian botanical extract supplier Indena.
High intake of the omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) could help protect the aging brain, according to research.
Israeli supplier Frutarom has expanded its Negev desert algae polysaccharide production potential by 30% to 10 tons in response to growing demand for the skin health products it is used in.
Some of the biggest names in US food manufacturing – including Nestle, Kellogg and Unilever - have been accused of infringing patents covering fats that alter the ratio of ‘good’ and ‘bad’ cholesterol in the blood.
Over 1.2 million American adolescents are taking supplements for sports performance, with multivitamins, fish oil and creatine the most popular, suggests a news survey.
Increased intakes of omega-3 fatty acids may reduce a specific marker of inflammation and confer heart and anti-cancer benefits, according to two new studies in the American Journal of Clinical Nutrition.
Mineral supplier Albion Laboratories, Inc., has acquired hundreds of intellectual property (IP) assets from the Procter & Gamble Company and its NutriStar business.
Uterine fibroids, the most common non-cancerous tumors in women of childbearing age, may be shrunk by vitamin D, suggests new data from a rat study funded by the National Institutes of Health.
Direct selling giant Amway is only one of many firms making deceptive and illegal disease prevention claims about immunity, according to the Center for Science in the Public Interest (CSPI).
Abbott Nutrition has unveiled plans to build a $270m nutrition manufacturing facility in Tipp City, Ohio, to make liquid nutrition products Ensure and Glucerna for the North American market.
The U.S. Food and Drug Administration (FDA) has issue a letter of no objection to the GRAS (Generally Recognized As Safe) status of OmniActive’s eye health ingredient Lutemax 2020.
TSI Group is splitting into two strategic divisions – Value Services and Innovation Products – as the Hong Kong registered company aims to double existing corporate business by 2015.
Women who experience painful menstrual cramps could find relief from high-dose vitamin D3, according to new research – which suggests the dietary supplement could provide an alternative to painkilling drugs that are currently used.
Many dietary supplement companies are not fully compliant with GMP regulations, putting them at risk of warning letters and more, but resources are available to help companies prepare for an FDA inspection, says the Council for Responsible Nutrition (CRN).
Three months of supplementation with vitamin D, combined with calcium, more protein in the diet, and some expert advice, may reduce the number of falls in malnourished seniors, says a new study.
Canadian plant protein specialist Burcon NutraScience says it remains confident of finding a new partner to commercialize its canola proteins after it emerged that ADM will not now be taking the proteins to market – after eight years of talks.
A fish oil supplement enriched with DHA may benefit early communicative development in infants, says the first randomized controlled trial testing high dose omega-3 on brain development in non-premature infants
A new joint venture between Mead Johnson Nutrition and SanCor Cooperativas Unidas Ltda. of Argentina is targeting a range of innovative nutritional products for infants and children in Argentina and the other Southern Cone markets.
The US Patent and Trademark Office (USPTO) has granted a request from Aker BioMarine to re-examine another US patent recently awarded to its arch rival Neptune Technologies & Bioressources.
A study of 25 healthy men has found DMAA-containing, pre-workout sports supplement, Jack3D, does not change resting heart rate, blood pressure or affect liver and kidney function when used at recommended dosage levels.
Israeli carotenoid supplier Algatechnologies has extended its AstaPure astaxanthin range with a 2%, water soluble version aimed at functional foods and cosmeceuticals markets.
Plant sterols in supplement form, and not formulated into margarine or other food products, may cut cholesterol levels by as much as 5%, says a new study.
The inventor of 'breathable' caffeine shot AeroShot Energy says he has barely scratched the surface when it comes to potential applications for the novel delivery format.
Daily supplements of vitamin D3 may improve certain markers of heart health like HDL cholesterol, and lead to significant reductions in body fat mass in overweight and obese people, says a new study.
DMAA-containing Jack3D and products like it are unauthorised drugs and being stripped from UK retail shelves and online catalogues as part of a crackdown against sports supplements by the medicines regulator, the MHRA.
The inaugural edition of Engredea will change the dialogue at trade shows, and connect true innovators with industry VIPs, according to the event’s executive director.
Fuji Health Science has received a no objections letter from the US Food and Drug Administration (FDA) responding to its new dietary ingredient (NDI) notification to up the permitted daily dosage of its AstaREAL branded astaxanthin to 12mg/day.
The Food and Drug Administration (FDA) is aiming to publish a proposed rule to reform the Nutrition Facts panel and related rules by the end of this year, somewhat later than originally expected.
US sales of calcium and calcium formula supplements slumped 3.5% in the past year against a backdrop of 8.1% growth in the overall dietary supplements market over the same period.
While bad press caused by a few unscrupulous players temporarily dented growth in the coral-derived calcium market, sales have now recovered strongly, according to one leading supplier.
Norwegian firm Calanus AS has applied to the UK Food Standards Agency for European Union novel foods approval to market an omega-3 oil derived from the miniature North Atlantic Ocean shrimp, Calanus finmarchicus.
Aker BioMarine has posted a 35% surge in sales of Superba krill oil in the fourth quarter of 2011 – selling a record 70 metric tons compared with 52t in Q4, 2010.
A new model to evaluate probiotic survival in the gut has confirmed that many bacteria strains survive better when consumed in a functional food matrix such as fermented milks – so allowing a greater chance to promote health, say the researchers.
Strong growth for Herbalife in the US is being driven by a new breed of young distributors dubbed ‘Generation H’, according to the direct sales supplement giant.
DNP International – the latest in a string of firms to be sued by Natural Alternatives International (NAI) for patent infringement over beta-alanine - insists the patent at issue is invalid and predicts it will “ultimately be vindicated” by the courts.
